Filing Details
- Accession Number:
- 0001179110-16-021665
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-03-15 09:00:50
- Reporting Period:
- 2016-03-11
- Filing Date:
- 2016-03-15
- Accepted Time:
- 2016-03-15 09:00:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1544227 | Ovascience Inc. | OVAS | Pharmaceutical Preparations (2834) | 451472564 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1551614 | Michelle Dipp | C/O Ovascience, Inc. 9 Fourth Ave. Waltham MA 02451 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-03-11 | 132,732 | $7.50 | 132,732 | No | 4 | P | Indirect | By Longwood Fund III LP |
Common Stock | Acquisiton | 2016-03-14 | 30,000 | $8.05 | 162,732 | No | 4 | P | Indirect | By Longwood Fund III LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By Longwood Fund III LP |
No | 4 | P | Indirect | By Longwood Fund III LP |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 971,921 | Direct |
Footnotes
- This Form 4 reflects the purchase of an aggregate of 162,732 shares purchased by Longwood Fund III LP in the market. The securities in this line are held directly by Longwood Fund III LP. Longwood Fund III GP, LLC is the general partner of Longwood Fund III LP. Voting and investment power with respect to the shares held by Longwood Fund III LP are vested in Richard Aldrich, Michelle Dipp, M.D., Ph.D. and Christoph Westphal, M.D., Ph.D. (collectively, the "Managers"), the managers of Longwood Fund III GP, LLC. Each of the Managers disclaims beneficial ownership of the shares held by Longwood Fund III LP, except to the extent of their respective pecuniary interest therein, and the inclusion of these shares in the report shall not be deemed an admission of beneficial ownership of the shares for the purposes of Section 16 or for any other purpose.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.70 to $8.10, inclusive. The Reporting Person undertakes to provide OvaScience, Inc., any security holder of OvaScience, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges sent forth in this footnote.